Dr. George Yancopoulos is the CEO of Regeneron, maker of one of two experimental therapies for the treatment of “mild to moderate” cases of Covid-19 that was authorized by the US’ Food and Drug Administration. George Yancopoulos is the founding scientist and Chief Scientific Officer of Regeneron Pharmaceuticals, working alongside Founder and Chief Executive Officer […] Read the full story on GreekReporter.com.